Plain-English translation of NCT06558708 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two new insulin medications— and GZR33-70 Injection—to see which works better for people whose type 2 diabetes is not well controlled by their current insulin treatment. You would receive one of these new injections once daily (possibly with an additional meal-time insulin injection) and your dose would be adjusted to reach your target blood sugar goals. Researchers want to understand how well each medication works, how easy it is to tolerate, and what side effects occur.
Many people with type 2 diabetes take insulin but still struggle to keep their blood sugar at healthy levels. This trial exists to see whether these two newer insulin formulations might work better than current options for people in that situation.
You likely qualify if…
You likely don't qualify if…
You would receive one of the two new insulin injections once daily by injection under the skin, with your dose adjusted over time to reach your target blood sugar level. Depending on your individual needs, you might also receive an additional insulin injection before dinner. The trial will monitor how well the medication works, how you tolerate it, and any side effects that occur. You'll be followed throughout the study period with regular check-ins to assess your blood sugar control and safety.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China